Feedback
DRREDDY 
Reputation: 642,713 • Jul 13, 2023 3:23 PM
USFDA accepts Dr Reddy's Biologics License Application for review; stock dips
Dr. Reddy’s rituximab biosimilar has already been approved for marketing in India and over 25 emerging markets.
Moneycontrol
1 Vote
Comment
Share
NSE:DRREDDY price when posted: 5,175.45
View Votes